Global Blood Therapeutics Inc is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. GBT has around 6.6M shares in the U.S. ETF market. The largest ETF holder of GBT is the Vanguard Small-Cap ETF (VB), with approximately 1.46M shares. Investors may also find of interest that the ETF with the largest allocation to GBT stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 4.23%. On average, U.S. ETFs allocate 0.39% of GBT to their portfolios.
Additionally, GBT is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GBT as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 35.89%.